Press Releases from Barcelona Science Park (8 total)
A consortium led by Hemostatics receives €2.5 M to validate a revolutionary th …
A public-private consortium formed by the biotech Hemostatics, based at the Barcelona Science Park, the Clínica Universidad de Navarra (CUN) and the Institut Català d'Investigació Química (ICIQ), has received 2.5 million euros from AEI, the State Investigation Agency, under the call for grants for Public-Private Collaboration Projects, to accelerate the development of an innovative treatment aimed at controlling disabling and lethal haemorrhage.
The aim of the project, led by Hemostatics -…
GENESIS Biomed consolidates its growth in the biomedical sector
The consultancy firm GENESIS Biomed -with its central offices at the Barcelona Science Park and offices in Madrid and Valencia, and a reference in advisory services for R&D&i projects in the biomedical sector- will close this financial year with a record turnover of €2M, 25% more than in 2022, thanks to an exclusively organic growth strategy and an ambitious national expansion plan.
In 2023, the consultancy, founded by Josep Lluís Falcó…
MeteoSim wins World Bank competition to implement a numerical weather forecastin …
MeteoSim, the global leader in the provision of meteorological and environmental services, has won a prestigious competition sponsored by the World Bank as part of its Development Project P161392: the "Malawi Resilience and Disaster Risk Management Project", to implement a numerical weather forecasting model for Department of Climate Change and Meteorological Services of Malawi to train the country's meteorological team, thus reinforcing their position as a global benchmark in the…
Barcelona Science Park refinances the €36.7 M debt with the Ministry of Scienc …
Barcelona Science Park (PCB) has refinanced the €36.7 M debt due with the Ministry of Science and Innovation over 25 years. This new schedule allows the PCB to have a stable financial position, both in the short and the long term, as well as consolidating its self-sustaining financial feasibility. The Government of Catalonia and the University of Barcelona support the refinancing, the first offering itself as a guarantor to the…
Schülke & Mayr GmbH acquires Spanish company Vesismin Health
Schülke & Mayr GmbH, a leading global provider in the fields of infection prevention and hygiene solutions in healthcare, acquires Vesismin Health, based in the Barcelona Science Park. The Spanish company was founded in 2004 as a project within the IQS university center by Víctor Vallés. Since then, its main goal is the close collaboration with healthcare centres in their fight to face healthcare-associated infections (HAIs) by providing effective, innovative…
Vesismin creates pioneering programme with comprehensive approach to hospital in …
Vesimin Health, based at the Barcelona Science Park and specialising in R&D and commercialising innovative solutions to control infections in hospital settings, has created Vesismin Services, the first comprehensive programme to provide guidance for professionals at hospitals and health centres in assessing protocols and practices for preventing and controlling healthcare-associated infections (HAIs).
The innovation of this pioneering project lies in its comprehensive guidance service with a global approach that facilitates traceability…
More than 1,750 students participate in the 2nd edition launch of “Reimagine S …
More than 1,750 young high school students from all over Catalonia participate in the launch of the second edition of “Reimagine Science: clinical trials, research and drug development” programme by Novartis, the Barcelona Science Park and Big Van Ciencia. The initiative aims to bring clinical research closer to both students and teachers to reflect together, through new formats, on the importance, development, and the factors and actors involved.
“Reimagine Science”…
Moirai Biodesign launches a best-in-class software for the design of complex RNA …
Moirai Biodesign –a biotech startup located at the Barcelona Scientific Park, pioneer in the development of RNA-based solutions for the development of new therapies and diagnostic systems– has launched MoiRNAiFold, a best-in-class software for the design of complex RNA molecules. The biotech startup promote by expert researchers in computational biology and synthetic biology -and currently led by Amadís Pagès (CEO), Ivan Dotu (CTO) and Daniel Poglayen (CPDO), makes the…
